These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 16613529)

  • 1. The great debate part II: should managed care rely on cost sharing to manage big-ticket biologics?
    Zitter M
    Am J Manag Care; 2006 Apr; 12(6 Suppl):S153-8; discussion S167-72; quiz S173-6. PubMed ID: 16613529
    [No Abstract]   [Full Text] [Related]  

  • 2. The case for cost sharing for biologic therapies.
    Fish L
    Am J Manag Care; 2006 Apr; 12(6 Suppl):S159-61; discussion S167-72; quiz S173-6. PubMed ID: 16613530
    [No Abstract]   [Full Text] [Related]  

  • 3. Balancing quality employee benefits with cost sharing.
    Lenda WM
    Am J Manag Care; 2006 Apr; 12(6 Suppl):S165-6; discussion S167-72; quiz S173-6. PubMed ID: 16613532
    [No Abstract]   [Full Text] [Related]  

  • 4. The case against excessive cost sharing.
    Brixner DI
    Am J Manag Care; 2006 Apr; 12(6 Suppl):S162-4; discussion S167-72; quiz S173-6. PubMed ID: 16613531
    [No Abstract]   [Full Text] [Related]  

  • 5. The future of prescription drug cost-sharing: real progress or dropped opportunity?
    Fairman KA
    J Manag Care Pharm; 2008; 14(1):70-82. PubMed ID: 18240885
    [No Abstract]   [Full Text] [Related]  

  • 6. Patient cost sharing: how much is too much?
    Trude S
    Issue Brief Cent Stud Health Syst Change; 2003 Dec; (72):1-4. PubMed ID: 14696651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medicare formulary coverage for top-selling biologics.
    Liang SY; Haas JS; Phillips KA
    Nat Biotechnol; 2009 Dec; 27(12):1082-4. PubMed ID: 20010576
    [No Abstract]   [Full Text] [Related]  

  • 8. Financial incentives and drug spending in managed care.
    Hillman AL; Pauly MV; Escarce JJ; Ripley K; Gaynor M; Clouse J; Ross R
    LDI Issue Brief; 1999 May; 4(1):1-4. PubMed ID: 12523336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specialty pharmacy management adjusts to new financial realities.
    Reinke T
    Manag Care; 2013 Apr; 22(4):13-4. PubMed ID: 23678558
    [No Abstract]   [Full Text] [Related]  

  • 10. Copayments dominate drug cost sharing choices.
    Manag Care; 2012 Nov; 21(11):55. PubMed ID: 23240146
    [No Abstract]   [Full Text] [Related]  

  • 11. A new method for determining patient payments for outpatient drugs.
    Goldman DP; Lakdawalla D
    Am J Manag Care; 2002 Feb; 8(2):125, 128, 130. PubMed ID: 11853200
    [No Abstract]   [Full Text] [Related]  

  • 12. Stats & facts. More consumer cost sharing in pharmacy benefit.
    Manag Care Interface; 2002 Apr; 15(4):34-5. PubMed ID: 11979701
    [No Abstract]   [Full Text] [Related]  

  • 13. Patient cost-sharing innovations: promises and pitfalls.
    Trude S; Grossman JM
    Issue Brief Cent Stud Health Syst Change; 2004 Jan; (75):1-4. PubMed ID: 14976991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Good research practices for measuring drug costs in cost-effectiveness analyses: a managed care perspective: the ISPOR Drug Cost Task Force report--Part III.
    Mansley EC; Carroll NV; Chen KS; Shah ND; Piech CT; Hay JW; Smeeding J
    Value Health; 2010; 13(1):14-7. PubMed ID: 19883404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Average out-of-pocket health care costs for Medicare+Choice enrollees increase substantially in 2002.
    Gold M; Achman L
    Issue Brief (Commonw Fund); 2002 Nov; (575):1-8. PubMed ID: 12425302
    [No Abstract]   [Full Text] [Related]  

  • 16. Are premium increases only a short-term antidote?
    Fine A
    Exec Solut Healthc Manag; 1999 Jul; 2(7):2-3. PubMed ID: 10539303
    [No Abstract]   [Full Text] [Related]  

  • 17. Controlling increases in the volume and intensity of medical services.
    Cave DG
    Empl Benefits J; 1993 Jun; 18(2):11-8. PubMed ID: 10126124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk contractors take aim at skyrocketing drug costs.
    Capitation Manag Rep; 1998 Sep; 5(9):129-34. PubMed ID: 10186047
    [No Abstract]   [Full Text] [Related]  

  • 19. Biologics trend leads pharmaceuticals.
    Manag Care; 2005 Sep; 14(9):66. PubMed ID: 16238263
    [No Abstract]   [Full Text] [Related]  

  • 20. Prescription costs become harder to swallow. Providers and payers get a big dose of reality with explosive spending and patient demand for new drugs.
    Hensley S
    Mod Healthc; 1999 Aug; 29(34):30-4. PubMed ID: 10557476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.